XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.08%6.11B | 3.53%1.58B | 3.76%1.51B | 3.92%1.51B | 5.14%1.5B | 9.16%5.87B | 6.41%1.53B | 10.52%1.46B | 9.74%1.45B | 10.22%1.43B |
Operating revenue | 4.08%6.11B | 3.53%1.58B | 3.76%1.51B | 3.92%1.51B | 5.14%1.5B | 9.16%5.87B | 6.41%1.53B | 10.52%1.46B | 9.74%1.45B | 10.22%1.43B |
Cost of revenue | 1.15%3.32B | 3.24%874.1M | 2.21%827.5M | -1.99%799.1M | 1.05%816.3M | 4.92%3.28B | 1.58%846.7M | 5.47%809.6M | 4.55%815.3M | 8.47%807.8M |
Gross profit | 7.79%2.79B | 3.90%707.9M | 5.69%683.1M | 11.46%712.1M | 10.45%687M | 15.04%2.59B | 13.08%681.3M | 17.57%646.3M | 17.16%638.9M | 12.58%622M |
Operating expense | 6.19%1.63B | -3.01%451.2M | 6.91%417.5M | 8.66%375.2M | 15.72%382M | 23.36%1.53B | 19.31%465.2M | 32.01%390.5M | 21.71%345.3M | 21.45%330.1M |
Selling and administrative expenses | 6.19%1.63B | -3.01%451.2M | 6.91%417.5M | 8.66%375.2M | 15.72%382M | 23.36%1.53B | 19.31%465.2M | 32.01%390.5M | 21.71%345.3M | 21.45%330.1M |
-Selling and marketing expense | 8.86%698.1M | -5.07%207.9M | 10.73%185.8M | 15.28%152.4M | 24.28%152M | 19.82%641.3M | 15.45%219M | 19.26%167.8M | 28.47%132.2M | 20.02%122.3M |
-General and administrative expense | 4.27%927.8M | -1.18%243.3M | 4.04%231.7M | 4.55%222.8M | 10.68%230M | 26.03%889.8M | 22.98%246.2M | 43.58%222.7M | 17.87%213.1M | 22.31%207.8M |
Operating profit | 10.10%1.16B | 18.79%256.7M | 3.83%265.6M | 14.75%336.9M | 4.49%305M | 4.82%1.06B | 1.65%216.1M | 0.75%255.8M | 12.23%293.6M | 3.99%291.9M |
Net non-operating interest income expense | 29.83%-68.7M | 30.19%-14.8M | 43.61%-12.8M | 16.85%-23.2M | 13.19%-25M | -14.10%-97.9M | 19.08%-21.2M | 4.22%-22.7M | -44.56%-27.9M | -73.49%-28.8M |
Non-operating interest income | 102.31%26.3M | 48.28%8.6M | 135.56%10.6M | ---- | ---- | 242.11%13M | --5.8M | --4.5M | ---- | ---- |
Non-operating interest expense | -14.34%95M | -13.33%23.4M | -13.97%23.4M | -16.85%23.2M | -13.19%25M | 23.77%110.9M | -10.00%27M | 14.77%27.2M | 44.56%27.9M | 73.49%28.8M |
Other net income (expense) | -4,393.67%-339.2M | 3,633.33%11.2M | -39,455.56%-354.2M | 83.78%6.8M | -28.07%4.1M | 101.98%7.9M | 100.07%300K | -79.07%900K | -11.90%3.7M | 171.43%5.7M |
Earnings from equity interest | 4.60%9.1M | 216.67%1.9M | 76.47%3M | 55.00%3.1M | -75.00%1.1M | -29.27%8.7M | -73.91%600K | -54.05%1.7M | -48.72%2M | 83.33%4.4M |
Special income (charges) | ---357.1M | --0 | ---357.1M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
-Less:Impairment of capital assets | --357.1M | --0 | --357.1M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Other non- operating income (expenses) | 1,200.00%8.8M | 3,200.00%9.3M | 87.50%-100K | 117.65%3.7M | 130.77%3M | 20.00%-800K | 81.25%-300K | -233.33%-800K | 466.67%1.7M | 533.33%1.3M |
Income before tax | -21.82%756.3M | 29.66%253.1M | -143.33%-101.4M | 18.97%320.5M | 5.69%284.1M | 84.87%967.4M | 187.18%195.2M | -0.21%234M | 9.29%269.4M | 0.98%268.8M |
Income tax | -19.26%171M | 53.98%63.9M | -146.55%-26.3M | 59.75%77M | -14.02%56.4M | 93.60%211.8M | 170.10%41.5M | 19.20%56.5M | -18.86%48.2M | 6.15%65.6M |
Net income | -22.54%585.3M | 23.10%189.2M | -142.31%-75.1M | 10.08%243.5M | 12.06%227.7M | 82.56%755.6M | 193.32%153.7M | -5.13%177.5M | 18.23%221.2M | -0.59%203.2M |
Net income continuous Operations | -22.54%585.3M | 23.10%189.2M | -142.31%-75.1M | 10.08%243.5M | 12.06%227.7M | 82.56%755.6M | 193.32%153.7M | -5.13%177.5M | 18.23%221.2M | -0.59%203.2M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -22.54%585.3M | 23.10%189.2M | -142.31%-75.1M | 10.08%243.5M | 12.06%227.7M | 82.56%755.6M | 193.32%153.7M | -5.13%177.5M | 18.23%221.2M | -0.59%203.2M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -22.54%585.3M | 23.10%189.2M | -142.31%-75.1M | 10.08%243.5M | 12.06%227.7M | 82.56%755.6M | 193.32%153.7M | -5.13%177.5M | 18.23%221.2M | -0.59%203.2M |
Basic earnings per share | -22.65%2.39 | 22.22%0.77 | -143.06%-0.31 | 11.11%1 | 13.25%0.94 | 81.76%3.09 | 192.65%0.63 | -6.49%0.72 | 16.88%0.9 | -1.19%0.83 |
Diluted earnings per share | -22.30%2.37 | 22.58%0.76 | -143.66%-0.31 | 11.24%0.99 | 13.41%0.93 | 81.55%3.05 | 191.18%0.62 | -6.58%0.71 | 17.11%0.89 | -1.20%0.82 |
Dividend per share | 4.13%1.135 | 4.13%0.2838 | 4.13%0.2838 | 4.13%0.2838 | 4.13%0.2838 | 3.81%1.09 | 3.81%0.2725 | 3.81%0.2725 | 3.81%0.2725 | 3.81%0.2725 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |